Scientific News Boston Scientific Resumes Enrolment In Pulsed Field Ablation Trial
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific Resumes Enrolment In Pulsed Field Ablation Trial is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Sham-Controlled Trial, and More, Bolster Pulsed-Field Ablation for AF
The PFA-SHAM trial and MANIFEST-US registry support the efficacy and safety of the increasingly used ablation modality. Read More
Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System
The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation MARLBOROUGH, Mass., July 7, 2025 /PRNewswire/ -- Boston Scientific ... Read More
Boston Scientific, Siemens Healthineers partner on cardiac catheter
Intended for use in structural heart procedures, the cardiac imaging catheter is expected to drive growth for Boston Scientific’s Watchman device. Read More
Boston Scientific Corp (BSX) Secures FDA Labeling Expansion for FARAPULSE Pulsed Field Ablation (PFA) System
Boston Scientific Corporation (NYSE:BSX) is one of Goldman Sachs’ top healthcare stock picks. On July 7, Boston Scientific (NYSE:BSX) saw its shares rise as TD Cowen reaffirmed its Buy rating and $115 ... Read More
Boston Scientific, Siemens Healthineers ink 4D ICE catheter development deal
Boston Scientific today announced a catheter development and commercialization deal with Siemens Healthineers. Read More
Boston Scientific expands Farapulse’s reach in afib with new FDA approval
Boston Scientific has claimed a new approval from the FDA for its Farapulse pulsed field ablation system, expanding its use into patients with persistent atrial fibrillation lasting at least seven ... Read More
Analysts project durable growth with many near-term catalysts for Boston Scientific
Analysts remain high on Boston Scientific (NYSE: BSX) after a visit to the company's Marlborough, Massachusetts headquarters. Read More
Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System
MARLBOROUGH, Mass., July 7, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use (IFU) ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus